GPCR/G protein

All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-   B6541 AH 11110 hydrochlorideSummary: α1B-AR ligand,subtype-selective B6541 AH 11110 hydrochlorideSummary: α1B-AR ligand,subtype-selective
-   B6362 Methiothepin maleateSummary: 5-HT antagonist B6362 Methiothepin maleateSummary: 5-HT antagonist
-   B6539 PindololSummary: β-adrenoceptor antagonist with partial agonist activity B6539 PindololSummary: β-adrenoceptor antagonist with partial agonist activity
-   B6353 N-Methylquipazine dimaleateSummary: 5-HT3 agonist B6353 N-Methylquipazine dimaleateSummary: 5-HT3 agonist
-   B6534 RS 79948 hydrochlorideSummary: α2-adrenoreceptor antagonist B6534 RS 79948 hydrochlorideSummary: α2-adrenoreceptor antagonist
-   B6352 α-Methyl-5-hydroxytryptamine maleateSummary: 5-HT2B receptor agonist B6352 α-Methyl-5-hydroxytryptamine maleateSummary: 5-HT2B receptor agonist
-   B6533 Imiloxan hydrochlorideSummary: α2-adrenoceptor antagonist B6533 Imiloxan hydrochlorideSummary: α2-adrenoceptor antagonist
-   B6347 Methylergometrine maleateTarget: 5-HT1 Receptor|5-HT2 ReceptorSummary: 5-HT1/5-HT2 receptor antagonist B6347 Methylergometrine maleateTarget: 5-HT1 Receptor|5-HT2 ReceptorSummary: 5-HT1/5-HT2 receptor antagonist
-   B6532 RS 17053 hydrochlorideSummary: α1A-adrenoceptor antagonist, novel and selective B6532 RS 17053 hydrochlorideSummary: α1A-adrenoceptor antagonist, novel and selective
-   B6334 4F 4PP oxalateSummary: 5-HT2A antagonist B6334 4F 4PP oxalateSummary: 5-HT2A antagonist
